
Jesse S Rosenthal, MD
About Me
Language
English
Position
ASSISTANT CLINICAL PROFESSOR | Psychiatry
Publications
Selected Publications
- Venlafaxine in the treatment of dysthymia: an open-label study.. D. J. Hellerstein, S. T. Batchelder, S. A. Little, M. J. Fedak, D. Kreditor, J. Rosenthal. Journal of Clinical Psychiatry
- Follow-up assessment of medication-treated dysthymia. David J. Hellerstein, Lisa Wallner Samstag, Marc Cantillon, Martin Maurer, Jesse Rosenthal, Philip Yanowitch, Arnold Winston. Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Long-term treatment of double depression: A preliminary study with serotonergic antidepressants. David J. Hellerstein, Philip Yanowitch, Jesse Rosenthal, Camille Hemlock, Karén Kasch, Lisa Wallner Samstag, Arnold Winston. Progress in Neuro-Psychopharmacology and Biological Psychiatry
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Rosenthal has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.